Primo partners with ABX to bring PB01 closer to Taiwan’s prostate cancer market

In response to the growing burden of prostate cancer in Taiwan, Primo Biotechnology has formed a strategic partnership w...

March 21, 2025 | Friday | News
Japan's Taiho Pharma buys ADC firm Araris Biotech for $740 M

Japan-based Taiho Pharmaceutical and Araris Biotech AG, a Swiss biotechnology company developing next-generation antibod...

March 20, 2025 | Thursday | News
Indian pharma firm Cipla signs multi-regional licensing deal for ophthalmic care with Taiwan's Formosa

India-based Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals for the comme...

March 18, 2025 | Tuesday | News
BIOPLUS-INTERPHEX KOREA 2025: Pioneering the Future of Biopharma with Specialized Pavilions

Showcasing Innovation Through Specialized Pavilions BIX 2025 will spotlight four specialized pavilions, each dedicated ...

March 17, 2025 | Monday | News
Teva enhances pharma distribution system in China

Teva Hong Kong has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network (KLN)....

March 14, 2025 | Friday | News
Trends shaping the Healthcare and Bioscience industries in 2025

The year 2025 is set to be a pivotal year for the health, bioscience, and biopharma sectors, as emerging trends shape he...

March 11, 2025 | Tuesday | Opinion
Taiwan's Mycenax and Sartorius join forces to strengthen global biopharma manufacturing potentials

Taiwan's Mycenax and Sartorius have entered into a strategic partnership to create comprehensive biopharmaceutical manuf...

March 6, 2025 | Thursday | News
WuXi XDC and AbTis announce strategic partnership to advance next-generation ADCs

WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...

March 11, 2025 | Tuesday | News
Vetter boosts pharmaceutical storage capacity with major warehouse expansion

Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced a significant exp...

March 11, 2025 | Tuesday | News
Japan grants Orphan Drug Designation to Lundbeck's potential treatment for Multiple System Atrophy

The Ministry of Health, Labour, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundb...

March 11, 2025 | Tuesday | News
Indaptus Therapeutics extends patent portfolio in China, Japan, and Israel

US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...

March 7, 2025 | Friday | News
Australian govt invests $20 M to expand country's largest and only onshore manufacturer of IV fluids

The Albanese Labor Government is building Australia’s future by investing in an expansion of Australia’s ons...

March 7, 2025 | Friday | News
Astellas and Yaskawa to establish joint venture in Japan focused on cell therapy manufacturing

Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...

March 6, 2025 | Thursday | News
SK Chemicals inks agreement with Viatris to expand pain management portfolio in Korea

SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pai...

March 6, 2025 | Thursday | News
Antengene expands commercial presence in APAC with XPOVIO's approval in Indonesia for cancer treatment

China's oncology firm Antengene Corporation has announced that the Indonesia National Agency of Drug and Food Control (B...

March 6, 2025 | Thursday | News
China Bans Illumina, Deepening U.S.-China Trade Rift and Reshaping Global Biotech

  Amid intensifying U.S.-China trade tensions, Beijing has escalated its retaliatory measures by banning U.S. biot...

March 5, 2025 | Wednesday | Analysis
Taiwan's Formosa Group invests $12.5 M to establish biomedical research centre in Korea

Taiwan-based Formosa Group Executive Committee member and Chairman Sandy Wang, who leads the group's bio and eco-friendl...

March 5, 2025 | Wednesday | News
Avecho and Sandoz announce $16 M deal to commercialise CBD for insomnia treatment in Australia

Avecho Biotechnology has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG for the c...

March 5, 2025 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls